tradingkey.logo
tradingkey.logo

Insulet Corp

PODD
289.040USD
-3.850-1.31%
終値 01/09, 16:00ET15分遅れの株価
20.33B時価総額
82.50直近12ヶ月PER

Insulet Corp

289.040
-3.850-1.31%

詳細情報 Insulet Corp 企業名

Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, and the Omnipod Insulin Management System. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen’s Neulasta to help reduce the risk of infection after intense chemotherapy.

Insulet Corpの企業情報

企業コードPODD
会社名Insulet Corp
上場日May 15, 2007
最高経営責任者「CEO」Mcevoy (Ashley)
従業員数3900
証券種類Ordinary Share
決算期末May 15
本社所在地100 Nagog Park
都市ACTON
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号01720-3440
電話番号19786007000
ウェブサイトhttps://www.omnipod.com
企業コードPODD
上場日May 15, 2007
最高経営責任者「CEO」Mcevoy (Ashley)

Insulet Corpの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Jessica Hopfield, Ph.D.
Dr. Jessica Hopfield, Ph.D.
Independent Director
Independent Director
27.70K
+778.00%
Mr. Michael R. Minogue
Mr. Michael R. Minogue
Independent Director
Independent Director
14.85K
-1380.00%
Mr. Eric Benjamin
Mr. Eric Benjamin
Chief Operating Officer
Chief Operating Officer
10.47K
-4263.00%
Ms. Elizabeth H. (Bess) Weatherman
Ms. Elizabeth H. (Bess) Weatherman
Independent Director
Independent Director
5.24K
+778.00%
Ms. Lauren Budden
Ms. Lauren Budden
Chief Accounting Officer, Group Vice President, Corporate Controller
Chief Accounting Officer, Group Vice President, Corporate Controller
5.22K
+759.00%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Independent Director
Independent Director
3.85K
+962.00%
Ms. Laetitia Cousin
Ms. Laetitia Cousin
Senior Vice President - Regulatory Affairs, Quality Assurance and Compliance
Senior Vice President - Regulatory Affairs, Quality Assurance and Compliance
3.58K
--
Mr. Prem Singh
Mr. Prem Singh
Senior Vice President - Global Operations
Senior Vice President - Global Operations
3.56K
-687.00%
Dr. Luciana Borio, M.D.
Dr. Luciana Borio, M.D.
Independent Director
Independent Director
3.09K
-481.00%
Mr. Timothy J. (Tim) Scannell
Mr. Timothy J. (Tim) Scannell
Independent Chairman of the Board
Independent Chairman of the Board
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Jessica Hopfield, Ph.D.
Dr. Jessica Hopfield, Ph.D.
Independent Director
Independent Director
27.70K
+778.00%
Mr. Michael R. Minogue
Mr. Michael R. Minogue
Independent Director
Independent Director
14.85K
-1380.00%
Mr. Eric Benjamin
Mr. Eric Benjamin
Chief Operating Officer
Chief Operating Officer
10.47K
-4263.00%
Ms. Elizabeth H. (Bess) Weatherman
Ms. Elizabeth H. (Bess) Weatherman
Independent Director
Independent Director
5.24K
+778.00%
Ms. Lauren Budden
Ms. Lauren Budden
Chief Accounting Officer, Group Vice President, Corporate Controller
Chief Accounting Officer, Group Vice President, Corporate Controller
5.22K
+759.00%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Independent Director
Independent Director
3.85K
+962.00%

収益内訳

通貨: USD更新時刻: Tue, Jan 6
通貨: USD更新時刻: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
事業別USD
会社名
収益
比率
U.S.Omnipod
497.10M
70.38%
International Omnipod
202.10M
28.61%
Drug Delivery
7.10M
1.01%
地域別USD
会社名
収益
比率
United States
504.20M
71.39%
All Other
202.10M
28.61%
事業別
地域別
事業別USD
会社名
収益
比率
U.S.Omnipod
497.10M
70.38%
International Omnipod
202.10M
28.61%
Drug Delivery
7.10M
1.01%

株主

更新時刻: Sat, Jan 10
更新時刻: Sat, Jan 10
株主統計
種類
株主統計
株主統計
比率
The Vanguard Group, Inc.
12.46%
Fidelity Management & Research Company LLC
9.83%
Capital Research Global Investors
6.47%
BlackRock Institutional Trust Company, N.A.
6.29%
State Street Investment Management (US)
4.39%
他の
60.56%
株主統計
株主統計
比率
The Vanguard Group, Inc.
12.46%
Fidelity Management & Research Company LLC
9.83%
Capital Research Global Investors
6.47%
BlackRock Institutional Trust Company, N.A.
6.29%
State Street Investment Management (US)
4.39%
他の
60.56%
種類
株主統計
比率
Investment Advisor
64.88%
Investment Advisor/Hedge Fund
23.47%
Hedge Fund
4.88%
Pension Fund
2.61%
Research Firm
2.52%
Sovereign Wealth Fund
1.57%
Bank and Trust
1.22%
Individual Investor
0.30%
Family Office
0.05%

機関投資家保有株

更新時刻: Thu, Jan 1
更新時刻: Thu, Jan 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
1560
71.31M
101.37%
-3.40M
2025Q3
1546
72.07M
102.39%
-3.66M
2025Q2
1541
72.80M
103.47%
-3.81M
2025Q1
1569
72.82M
103.50%
-3.52M
2024Q4
1508
72.57M
103.34%
-4.94M
2024Q3
1436
73.14M
104.31%
-3.15M
2024Q2
1408
72.17M
103.04%
-3.02M
2024Q1
1350
71.60M
102.26%
-3.12M
2023Q4
1320
72.91M
104.42%
-1.52M
2023Q3
1254
72.05M
103.19%
-4.06M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
The Vanguard Group, Inc.
8.76M
12.46%
+86.58K
+1.00%
Sep 30, 2025
Fidelity Management & Research Company LLC
6.91M
9.83%
+58.10K
+0.85%
Sep 30, 2025
Capital Research Global Investors
4.55M
6.47%
-187.06K
-3.95%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
4.43M
6.29%
+74.83K
+1.72%
Sep 30, 2025
State Street Investment Management (US)
3.09M
4.39%
+33.93K
+1.11%
Sep 30, 2025
Baillie Gifford & Co.
2.09M
2.97%
-43.37K
-2.03%
Sep 30, 2025
Geode Capital Management, L.L.C.
1.97M
2.79%
+37.85K
+1.96%
Sep 30, 2025
ClearBridge Investments, LLC
1.47M
2.09%
-69.39K
-4.52%
Sep 30, 2025
American Century Investment Management, Inc.
1.41M
2%
+97.19K
+7.42%
Sep 30, 2025
Fidelity International
1.11M
1.58%
-19.10K
-1.69%
Sep 30, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
Langar Global HealthTech ETF
7.26%
Innovator IBD Breakout Opportunities ETF
4.88%
Global X HealthTech ETF
4.76%
Goldman Sachs Future Health Care Equity ETF
4.2%
First Trust Nasdaq Lux Digi Health Solutions ETF
3.7%
iShares Health Innovation Active ETF
3%
Congress SMid Growth ETF
2.82%
iShares U.S. Medical Devices ETF
2.62%
FT Raymond James Multicap Growth Equity ETF
2.3%
Acruence Active Hedge US Equity ETF
2.27%
詳細を見る
Langar Global HealthTech ETF
比率7.26%
Innovator IBD Breakout Opportunities ETF
比率4.88%
Global X HealthTech ETF
比率4.76%
Goldman Sachs Future Health Care Equity ETF
比率4.2%
First Trust Nasdaq Lux Digi Health Solutions ETF
比率3.7%
iShares Health Innovation Active ETF
比率3%
Congress SMid Growth ETF
比率2.82%
iShares U.S. Medical Devices ETF
比率2.62%
FT Raymond James Multicap Growth Equity ETF
比率2.3%
Acruence Active Hedge US Equity ETF
比率2.27%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
種類
比率
データなし
日付
種類
比率
データなし

よくある質問

Insulet Corpの上位5名の株主は誰ですか?

Insulet Corpの上位5名の株主は以下のとおりです。
The Vanguard Group, Inc.は8.76M株を保有しており、これは全体の12.46%に相当します。
Fidelity Management & Research Company LLCは6.91M株を保有しており、これは全体の9.83%に相当します。
Capital Research Global Investorsは4.55M株を保有しており、これは全体の6.47%に相当します。
BlackRock Institutional Trust Company, N.A.は4.43M株を保有しており、これは全体の6.29%に相当します。
State Street Investment Management (US)は3.09M株を保有しており、これは全体の4.39%に相当します。

Insulet Corpの株主タイプ上位3種は何ですか?

Insulet Corpの株主タイプ上位3種は、
The Vanguard Group, Inc.
Fidelity Management & Research Company LLC
Capital Research Global Investors

Insulet Corp(PODD)の株式を保有している機関の数はいくつですか?

2025Q4時点で、Insulet Corpの株式を保有している機関は1560社あり、保有株式の総市場価値は約71.31Mで、全体の101.37%を占めています。2025Q3と比較して、機関の持ち株は-1.02%増加しています。

Insulet Corpの最大の収益源は何ですか?

FY2025Q3において、U.S.Omnipod部門がInsulet Corpにとって最大の収益を生み出しており、その金額は497.10Mで、全収益の70.38%を占めています。
KeyAI